Abstract
The rate of cell division in multicellular organisms is controlled by humoral signals (e.g., hormones, growth factors, transport proteins or low-density lipoproteins), cell-to-cell interactions (e.g., contact inhibition), and cell-inherent factors such as certain genes and the associated gene products. Under physiological conditions there is a balance between creation and death of cells in response to requirement. For example, in case of local cell destruction fibroblasts, endothelia, pericytes, possibly keratinocytes, osteocytes, and other cell populations start to divide. Subsequent to repairment the cells stop growing. This process of growth regulation is under the control of various local signals. It is unclear up to now whether similar, but pathological, mechanisms also play a role in cell transformation with uncontrolled proliferation. Besides such local growth control many humoral factors are known to regulate cell proliferation. A prerequisite for the effectiveness of such growth-regulating substances are cellular receptors of the target cells through which the signals are transmitted into the cells to switch on and off the corresponding genes.
This work was supported by the Deutsche Forschungsgemeinschaft, SFB 232 (Hamburg) and grant Di 276/1–2, as well as by the Hamburger Krebsgesellschaft, the Hamburger Stiftung zur Förderung der Krebsbekämpfung and the Erich und Gertrud Roggenbruck-Stiftung.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD (1983) Molecular biology of the cell. Garland, New York, pp 951–1012
Berridge MJ (1981) Receptor and calcium signalling. In: Lamble JW (ed) Towards understanding of receptors. Elsevier North Holland, New York, pp 122–131
Berridge MJ, Irvine RF (1984) Inositol triphosphate a novel second messenger in cellular signal transduction. Nature 312: 315–321
Bishop JM (1985) Viruses, genes and cancer II. Retrovirus and cancer genes. Cancer 55: 2329–2333
Brown MS, Anderson RGW, Goldstein JL (1983) Recycling receptors: the round trip itinerary of migrant membrane proteins. Cell 32: 663–667
Cantrell DA, Smith KA (1984) The interleukin 2—T-cell system: a new cell growth model. Science 224: 1316–1316
Carafoli E, Peneston JT (1986) The calcium signal. Sci Am (Germ edn) Jan 1: 76–85
Carpenter G, Cohen S (1979) Epidermal growth factor. Annu Rev Biochem 48: 193–216
Catt KJ, Harwood JP, Aguilera G, Dufau ML (1979) Hormonal regulation of peptide receptors and target cell responses. Nature 280: 109–116
Colston K, Colston MJ, Fieldsteel AH, Feldman D (1982) 1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines. Cancer Res 42: 856–859
Cooper JA, Hunter T (1983) Regulation of cell growth and transformation by tyrosine-specific protein kinase: the search for important cellular substrate proteins. In: Vogt PK, Kiprowski H (eds) Retroviruses 2. Current Topic Microbiology and Immunology, vol 107. Springer, Berlin Heidelberg New York, pp 125–161
Cuttitta F, Carney DN, Mulshine J, Moody TW, Fedorko J, Fischler A, Minna JD (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316: 823–826
Dales S (1973) Early events in cell-animal virus interaction. Bacteriol Rev 37: 103–135
Dietel M (1982) Functional morphology and pathology of parathyroid glands. Fischer, Stuttgart
Dietel M (1986) Cell receptors—functions and deficiencies. Verh Dtsch Ges Pathol 70: 4–17
Dietel M (1987) What’s new in receptor mediated growth promotion of normal and malignant cells? Pathol Res Pract 182: 431–442
Dietel M, Dorn G, Montz R, Altenähr E (1979) Influence of vitamin D3, 1,25-dihydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion, adenosine 3’, 5’-monophosphate release, and ultrastructure of parathyroid glands in organ culture. Endocrinology 105: 237–245
Dietel M, Hölzel F, Arps H, Simon WE, Albrecht M (1985) Mamma carcinomas in vitro: cytoskeleton, tumor makers, nuclear DNA, and rate of proliferation in relation to hormones and cytostatics. Verh Dtsch Ges Pathol 69: 212–217
Dietel M, Arps H, Klapdor R, Müller-Hagen S, Sieck M, Hoffmann L (1986) Antigen detection by the monoclonal antibodies CA 19–9 and CA 125 in normal and tumor tissue and patients’ sera. Cancer Res Clin Oncol 111: 257–265
Eisman JA, Frampton RJ, Sher E, Suva U, Martin TJ (1983) Presence and role of 1,25dihydroxyvitamin D receptors in human cancer cells. In: Meyskens FL, Prasad KN (eds) Modulation and mediation of cancer by vitamins, 282–286. Karger, Basel
Emerman JT, Leathy M, Gout PW, Brucjovsky N (1985) Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res 17: 421–424
Geller J, Albert JD (1984) Antiandrogen and small dose of estrogen therapy as preferred treatment for prostate carcinoma. In: Hormones and cancer. Raven, New York
Goldstein JL, Anderson RGW, Brown MS (1979) Coated pits, coated vesicles and receptormediated endocytosis. Nature 279: 679–685
Green AR, Wyke JA (1985) Anti-oncogenes. A subset of regulatory genes involved in carcinogenesis. Lancet II (8453): 475–477
Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P (1986) Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320: 134–139
Green GL, Nolan C, Engler JP, Jensen EV (1980) Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci USA 77: 5115–5119
Greenway B, Igbal MJ, Johnson PJ, Williams R (1981) Oestrogen receptor proteins in malignant and fetal pancreas. Br Med J 283: 751–753
Gullino PM (1981) Angiogenesis factor(s). In: Baserga R (ed) Tissue growth factors. Springer, Berlin Heidelberg New York, pp 427–450 (Handbook of experimental pharmacology, vol 57 )
Hannover JA, Dickson RB (1985) Transferrin: receptor mediated endocytosis and iron delivery. In: Pastan I, Willingham MC, (eds.) Endocytosis. Plenum, New York, pp 131–162
Helmreich EJM (1986) Fortschritte der molekularen Endokrinologie. Klin Wochenschr 64: 669–681
Hood LE, Weissman IL, Wood WB (1982) Immunology, 2nd edn. Benjamin Cummings Menlo Park, Ca
Horwitz KG, McGuire WL (1978) Nuclear mechanisms of estrogen action: effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J Biol Chem 253: 8185–8191
Hunter T, (1984) The proteins of oncogenes. Sci Am 251: 70–79
Hunter T, Sefton BM (1980) Transforming gene product of Rous sarcoma Virus phosphorylates tyrosine. Proc Natl Acad Sci USA 77: 1311–1315
Hynes RO (1985) Molecular biology of fibronectin. Annu Rev Cell Biol 1: 67–91
Imagawa W, Tomooka Y, Hamamoto S, Nandi S (1985) Stimulation of mammary epithelial cell gowth in vitro: interaction of epidermal growth factor and mammogenic hormones. Endocrinology 116: 1514–1524
Kamata N, Chida K, Rikimaru K, Horikoshi M, Enomoto S, Kuroki T (1986) Growth-inhibitory effects of epidermal growth factor and over expression of its receptors on human squamous cell carcinomas in culture. Cancer Res 46: 1648–1653
King WJ, Greene GL (1985) Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells. Nature 307: 745–747
Kinoshita Y, Fukase M, Takenaka M, Nakada M, Miyauchi A, Fujita T (1985) Calcitonin stimulation of cyclic adenosine 3’:5’-monophosphate production with growth inhibition in human renal adenocarcinoma cell lines. Cancer Res 45: 4890–4894
Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB (1987) Evidence that transforming growth factor-ß is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417–428
Kobayashi S, Mizuno T, Tobioka T (1982) Sex steroid receptors in diverse human tumors. Gann 73: 439–445
Land H, Prada LF, Weinberg RA (1983) Cellular oncogenes and multistep carcinogenesis. Science 222: 771–778
Lee PDK, Rosenfeld RG, Hintz RL, Smith SD (1986) Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J Clin Endocrinol Metab 62: 28–35
Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schlessinger J (1985) Amplification, enhances expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature 313: 144–147
Lindquist R, Vitols S, Gahrton G, Öst A, Peterson C (1985) Low density lipoprotein receptor activity in human leukemic cells—relation to chrmosome aberrations. Acta Med Scand 217: 553–558
Löser R, Seibel K, Roos W, Eppenberger U (1985) In vivo and In vitro antiestrogenic action of 3—hydroxytamoxifen, tamoxifen and 4-hydroxitamoxifen. Eur J Cancer Clin Oncol 21: 985–990
March M (1984) The entry of enveloped viruses into cells by endocytosis. Biochem J 218: 1–10
Markland FS, Chiopp RT, Cosgrove MD, Howard EB (1978) Characterization of steroid hormone receptors in the Dunning R-3327 rat prostatic adenocarcinoma. Cancer Res 38: 2818–2826
McDouglas JS, Kennedy MS, Sligh JM, Cort SP, Mawle A, Nicholson JKA (1986) Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 231: 382–385
Metcalf D (1981) Hemopoietic colony stimulating factors. In: Baserga R (Ed) Tissue growth factors. Springer, Berlin Heidelberg New York, pp 343–384 (Handbook of experimental pharmacology, vol 57 )
Musgrove E, Rugg C, Taylor I, Hedley D (1984) Transferrin receptor expression during exponential and plateau phase growth of human tumour cells in culture. J Cell Physiol 118: 6–12
Nagasue N, Ito A, Yukaya H, Ogawa Y (1986) Estrogen receptors in heptacellular carcinoma. Cancer 57: 87–91
Neal DE, Marsh C, Bennett MK, Abel PD, Hall RR, Sainsbury JRC, Harris Al (1985) Epidermal growth factor receptors in human bladder cancer: comparison of invasive and superficial tumors. Lancet: 366–368
Neumann F, Graf KJ, Hason SH, Schenche B, Steinbeck H (1977) Central actions of antiandrogens. In: Martini GA, Motta JB (eds) Androgens and antiandrogens. Raven, New York, pp 163–171
Niendorf A, Arps H, Dietel M (1987) Effect of 1,25-dihydroxyvitamin D3 on human cancer cells in vitro. J Steroid Biochem 27: 825–828
Pastan I, Willingham MC (1981) Journey to the center of the cell: role of the receptorsome. Science 214: 504–509
Pastan I, Willingham MC (1985) Endocytosis. Plenum, New York, pp 1–40 Paul J (1984) Oncogenes. J. Pathol 143: 1–10
Pike JW (1984) Monoclonal antibodies to chick intestinal receptors for 1,25-dihydroxyvitamin D3. J Biol Chem 259: 1167–1173
Poiesz BJ, Ruscetti FW, Mier JW, Woods AM, Gallo RC (1980) T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factors. Proc Natl Acad Sci USA 77: 6815–6819
Rapp UR, Bonner TI, Moelling K, Jansen HW, Bister K, Ihle J (1985) Genes and gene products involved in growth regulation of tumor cells. In: Havemann K, Sorenson G, Gropp C (eds) Peptide hormones in lung cancer. Springer, Berlin Heidelberg New York, pp 221–236 (Recent results in cancer research, vol 99 )
Redding TW, Schally AV (1984) Inhibition of growth of pancreatic carcinoma in animal models by analogs of hypothalamic hormones. Proc Natl Acad Sci USA 81: 248–256
Rochefort H, Bogna JL (1981) Differences between estrogen receptor and nuclear receptor processing. Nature 292: 257–259
Rose DP (1979) Endogenous hormones in the etiology and clinical course of breast cancer. In: Rose DP (ed) Endocrinology of cancer, vol 1. CRC, Boca Raton, pp 21–59
Sainsbury JRC, Farndon JR, Sherbet GV, Harris Al (1985) Epidermal growth factor receptors and estrogen receptors in human breast cancer. Lancet: 364–366
Schnipper LE (1986) Clinical implications of tumor-cell heterogeneity. N Engl J Med 314: 1423–1431
Sherr CJ, Rettenmier CW, Sacca R, Roussel MF, Look AT, Stanley ER (1985) The c fms protooncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 41: 665–676
Sica V, Nora E, Contieri E (1984) Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res 44: 4670–4674
Simon WE, Albrect M, Tram G, Dietel M, Hölzel F (1984) In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen and prolactin. J Natl Cancer Inst 73: 313–321
Sporn MB, Roberts AB (1985) Autocrine growth factor and cancer. Nature 313: 745–747 Sugamura K, Fuji M, Ishii T, Hinuma Y (1986) Possible role of interelukin 2 receptor in oncogenesis of HTLV-I/ATLV. Cancer Rev 1: 96–114
Tokunaga A, Nishi K, Matsukura N, Tanaka N, Onda M, Shirota A, Asano G, Hayashi K (1986) Estrogen and progesteron receptors in gastric cancer. 57: 1376–1379
Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Liberman TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfield MD, Seeburg PH (1984) Human epidermal growth factor receptor eDNA sequence and abberant expression of the amplified gene in A 431 epidermoid carcinoma cells. Nature 309: 418–425
Ushiro H, Cohen S (1980) Identification of phosphotyrosine as a product of epidermal growth factor activated protein kinase in A 431 cell membranes. J Biol Chem 255: 8263
Varmus HE (1985) Viruses, genes and cancer. I. The discovery of cellular oncogenes and their role in neoplasia. Cancer 55: 2324–2328
Vasilev JM (1985) Spreading of non-transformed and transformed cells. Biochim Biophys Acta 780: 21–65
Vermeer BJ, Wijsman MC, Mommaas-Kienhuis AM, Ponec M (1985) Modulation of low density lipoprotein receptor activity in squamous carcinoma cells by variation in cell density. Eur J Cell Biol 38: 353–360
Vitols S, Gahrton G, Peterson C (1984) Significance of the low density lipoprotein (LDL) receptor pathway for the in vitro accumulation of AD 32 incorporated into LDL in normal and leukemic white blood cells. Cancer Treat Rep 68: 515–520
Wanless IR, Medline A (1982) Role of estrogens as promotors of hepatic neoplasia. Lab Invest 46: 313–320
Waterfield MD, Scrace T, Whittle N (1983) Platelet-derived growth factor is structurally related to the putative transforming protein p28s`s of simian sarcoma virus. Nature 304: 35–39
Weinberg RA (1983) A molecular basis of cancer. Sci Am 249: 126–143
Willingham MC, Haigler HR, Fitzgerald DJR, Gallo MG, Rutherford AV, Pastan IH (1983) The morphological pathway of binding and internalization of epidermal growth factor in cultured cells. Exp Cell Res 146: 163–175
Yamamoto T, Kamata N, Kawano H, Shimitsu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I, Gamou S, Shimizu N (1986) High incidence of amplification of the EGF receptor gene in human squamous carcinoma cell lines. Cancer Res 46: 414–416
Zachary I, Sinnett-Smith JW, Rozengurt E (1986) Early events elicited by bombesin and structurally related peptides in quiescent Swiss 3T3 cells. I. Activation of protein kinase C and inhibition of epidermal growth factor binding. J Cell Biol 102: 2211–2222
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin·Heidelberg
About this paper
Cite this paper
Dietel, M., Niendorf, A. (1990). Cellular Receptors of Hormones and Nonhormone Ligands in Normal and Malignant Cells. In: Beck, L., Grundmann, E., Ackermann, R., Röher, HD. (eds) Hormone-Related Malignant Tumors. Recent Results in Cancer Research, vol 118. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83816-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-83816-3_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83818-7
Online ISBN: 978-3-642-83816-3
eBook Packages: Springer Book Archive